Rare case of angiofibroma presenting as perineal hernia

  1. Ruchika Kumari ,
  2. Cherring Tandup ,
  3. Ambuj Agarwal and
  4. Anish Chowdhury
  1. General Surgery, Post Graduate Institute of Medical Education and Research, Chandigarh, India
  1. Correspondence to Dr Cherring Tandup; ctandup@gmail.com

Publication history

Accepted:30 Nov 2020
First published:11 Jan 2021
Online issue publication:11 Jan 2021

Case reports

Case reports are not necessarily evidence-based in the same way that the other content on BMJ Best Practice is. They should not be relied on to guide clinical practice. Please check the date of publication.

Abstract

Angiofibroma is a benign soft tissue tumour presenting as a gradually progressive swelling in the vulvovaginal area in women and in the inguinoscrotal region in men. Being a rare tumour, there are only a few case reports in the literature, and among them, presentation as perineal herniation is very rare. En bloc resection of angiofibroma either via laparoscopic or open approach is the choice of treatment to avoid recurrence. Detailed pathological examination and immunohistochemistry workup are imperative to distinguish it from various mesenchymal tumours. Perineal hernia is itself rare and may occur spontaneously or following abdominoperineal resection, sacrectomy or pelvic exenteration. Surgical repair via open transabdominal and transperineal approaches has been described. Here, we report a case of a young woman who presented with spontaneous reducible perineal hernia with a soft tissue tumour as its content, which on histopathological investigation was found to be an angiofibroma.

Background

Nucci et al first described cellular angiofibroma in 1997 in a series of six female patients.1 The most common site of origin in women is the vulvovaginal region, and in men is the inguinoscrotal area. There is no sex predominance.2 Tumour size may vary from 0.6 to 25 cm.3 Most commonly, it presents either as a Bartholin’s cyst (48%), solid mass (28%), vulval cyst (12%) or lipoma. However, no case reports of angiofibroma presenting as perineal herniation has been reported. Though, a few case series of aggressive angiomyxoma as perineal herniation have been reported. Differential diagnoses of these tumours include many aggressively growing tumours, such as aggressive angiomyxoma and soft tissue sarcoma, which have a very high recurrence rate and have to be differentiated by immunohistochemistry.2 Treatment includes simple excision of the tumour to avoid recurrence in the future.3

Case presentation

A 31-year-old woman presented with swelling in the right gluteal region for the past 9 months associated with mild pain and discomfort on sitting. Swelling was reducible in nature, with no history of constipation, obstipation and abdominal distension. No history of urinary and gynaecological symptoms, and no history of surgery or admission in hospital.

On examination, a 15×10 cm firm, non-tender reducible swelling was present in the right gluteal region with normal overlying skin. Cough impulse was present. The patient was admitted a few months after the outpatient department visit, and on the day of admission, the swelling was irreducible with visible dilated veins over the swelling (figure 1). The per-abdomen examination was normal. Per-rectal examination revealed an extraluminal lump palpable on the right side.

Figure 1

Preoperative pictures of the tumour.

Investigations

She underwent an ultrasound, which reported a 14×6 cm elongated heteroechoic reducible structure herniating into the right gluteal region with a bulky uterus lying inferiorly, likely uterine prolapse. Doppler ultrasound demonstrated multiple venous channels with a flow velocity of 6–10 cm/s within the core of the tumour, suggestive of a vascular soft tissue lesion. Following ultrasound, contrast-enhanced MRI was performed, which reported a well-encapsulated area of size 8.7×14.5×24.2 cm with altered intensity on the right side of the pelvis. Heterogeneously isointense on T1 and hyperintense on T2 with heterogeneous post-contrast enhancement and few linear whirled hypointense foci. The mass was extending from the right adnexa into the perineal region, up to the right gluteal region. The mass was abutting the urinary bladder anteromedially, and uterus and rectum posteriorly, and was extending posteriorly to the presacral space. Laterally, it was abutting the lateral pelvic wall and the medial part of the right gluteus muscle. Fat planes were well maintained with the adjacent structure without any infiltration (figure 2). With the above-mentioned clinical assessment and radiological workup, a provisional diagnosis of irreducible perineal soft tissue tumour, probably an aggressive angiomyxoma, was kept as a provisional diagnosis. Further CT imaging of the chest and abdomen was performed for soft tissue tumour staging, which was normal.

Figure 2

MRI showingT2 hyperintense mass extending from the pelvis to the perineum through the levator ani. Post-contrast images showing a characteristic layered pattern or swirled appearance.

Treatment

She was laid in a modified lithotomy position and we approached the tumour both from the abdominal and perineal area as it was an irreducible, large tumour and complete excision required a good exposure. On exploration, a bulging mass was present in the retroperitoneal region of the right iliac fossa, which was lateral to the urinary bladder and extending downward into the pelvis and reaching up to the perineum through the pelvic inlet. The mass was soft in consistency and well-encapsulated. It was mobilised circumferentially inferiorly until the pelvis. The perineal approach with an inverted Y-shaped incision was made over the swelling. The 20×8×3.5 cm tubular mass was mobilised along with the capsule superiorly and was delivered out through the perineal incision (figure 3). Uterus, bilateral ovaries, urinary bladder and rectum were normal and not involved by the tumour. A perineal closed suction drain was placed and the skin was closed.

Figure 3

Postoperative picture of the tumour measuring 20×8×3.5 cm.

Histopathology reported a 17×16×7.3 cm size well-circumscribed benign tumour with no capsular breach. It was composed of an intricate mixture of stellate and staghorn blood vessels of various sizes in the fibrous stroma, which showed oedema and myxoid changes (figure 4). No atypia or increased mitosis was seen. Overall, the features were suggestive of angiofibroma. Immunohistochemistry of the tumour showed oestrogen receptor positivity with a Ki67 index of 3%.

Figure 4

Histopathology reported a 17×16×7.3 cm size well-circumscribed benign tumour with no capsular breach and composed of an intricate mixture of stellate and AMP; staghorn blood vessels of various sizes in the fibrous stroma which shows oedema and myxoid changes.

Outcome and follow-up

The patient did well after the surgery and is currently in follow-up. No adjuvant treatment is required. We have scheduled her for a 3-month follow-up for 1 year with clinical examination, and planned for contrast-enhanced CT of the abdomen/MRI of the abdomen at 6 months.

Discussion

Angiofibroma is a rare, well-circumscribed benign soft tissue tumour, first described by Nucci et al in 1997 as a vulvar lesion.1 In a case series of 51 patients, the most common site of angiofibroma was the vulvovaginal region in women and the inguinoscrotal region in men. There is no sex predominance. Size ranges from 0.6 cm to 25 cm, with most of the tumours being well-encapsulated. Microscopically, it is well-circumscribed, comprising spindle-shaped cells with collagen and numerous small-sized to medium-sized blood vessels. On immunohistochemistry, the tumour cells expressed CD34, SMA and desmin. In their follow-up, no patient developed recurrence or distant metastasis.3

Emtage et al in 2013 reported a case of a 58-year-old man who presented with a report of obstructed voiding and decreased ejaculation. On imaging, he was diagnosed to have a pelvis mass of size 7×7×5 cm on the right side of the prostate and extending to the bulbar urethra, which was managed with surgical excision.4

In 2015, Mandato et al reviewed 79 cases of angiofibroma in women from 1997 to 2014. Among these, in 73 cases, the tumours were arising in the vulvovaginal and pelvic region, while in the remaining 6 cases, they were extrapelvic in origin. All were treated with local excision of the tumour, out of which, 18 had positive surgical margin and among them 5 underwent re-excision. No recurrences and metastasis were reported in any case, even in those with positive resection margins.2

Among differential diagnoses for angiofibroma, many mesenchymal tumours can be considered, such as aggressive angiomyxoma, angiofibroblastoma, spindle cell lipoma and smooth muscle tumour. Immunohistochemistry staining can be used to differentiate these tumours and to indicate atypical and sarcomatous transformation of the same. Angiofibroma expresses vimentin, CD34, oestrogen and progesterone receptor. Oestrogen and progesterone receptor positive status suggest a hormonal origin in female patients, but until now, no definitive evidence is available due to scarcity of literature.2 In our patient, the tumour was oestrogen receptor positive. In a similar case report by Aydin et al in 2016, a 20×15×10 cm sized vulvar angiofibroma was treated with surgical resection. This was the largest angiofibroma reported to date. On histopathology, the tumour was well-encapsulated, and on immunohistochemistry, the tumour showed markers of oestrogen receptor, progesterone receptor, vimentin and CD34 with Ki67 of 3%–5%. At the 6-month follow-up, there was no local recurrence.5

Learning points

  • Angiofibroma is a rare benign soft tissue tumor commonly arising in the lower half of the body. Simple surgical excision is sufficient for management though en bloc resection must be performed as the lesion can manifest as aggressive mesenchymal tumours.

  • Spontaneous perineal herniation should be evaluated further with radiological imaging to know the exact content of the hernial sac.

  • Effective team management, including a surgeon, gynaecologist, radiologist and pathologist, is required for multidisciplinary team management of these rare tumours presenting as rare hernias.

Footnotes

  • Contributors The patient was admitted under CT. RK and AA were involved in the treatment of the patient. AC mentored in the treatment of the patient. I, RK and AA created this manuscript. AC and CT provided guidance for completing the manuscript.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Patient consent for publication Obtained.

  • Provenance and peer review Not commissioned; externally peer-reviewed.

References

Use of this content is subject to our disclaimer